StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Interpace Biosciences's EV/EBITDA was 29.3× on Oct 19, 2026, against 0.7× a year earlier. Over the last 2 years it ranged from 0.2× to 44.6×, with a median of 1.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202629.3×+28.5
2025Dec 31, 20250.8×−0.5
2024Dec 31, 20241.3×–

More Interpace Biosciences figures

See a number that looks wrong?